NEWS

TripleTree Advises Pulse8 on its Strategic Partnership with Veradigmâ„¢, an Allscripts Company

MAR 25, 2019
MINNEAPOLIS – March 25, 2019 – TripleTree, LLC, a strategic advisor and merchant bank serving innovative and market-leading companies in healthcare, is pleased to announce that it advised Pulse8 on its strategic partnership with Veradigm™, an Allscripts (NASDAQ: MDRX) company. Pulse8 is a leading healthcare analytics and technology company delivering a complete enterprise platform to provide visibility into the efficacy of Risk Adjustment, Quality Improvement, and Pharmacy Management programs for health plans and at-risk providers. 
 
Pulse8 strengthens Veradigm’s existing health plan product suite that delivers tools and services to help control costs while optimizing health outcomes for health plan members.  The newly combined offering of clinical data exchange solutions, cutting-edge analytics, and point-of-care engagement tools supports Veradigm’s commitment to health plans and health care providers in their drive towards quality outcomes while maximizing return on investment. 
 
“Pulse8 has distinguished itself through its ability to manage and analyze large volumes of data from disparate sources, creating actionable insights that drive enhanced performance across risk, care, and quality,” said Dave Brownlie, Managing Director at TripleTree. “We are thrilled for Pulse8, as this move will accelerate new innovation and unlock new opportunities to apply its analytics across a broader cross-section of healthcare constituents.”
 
“Pulse8 is dedicated to re-imagining data to help people live healthy and independent lives through the innovation of sophisticated analytics, predictive techniques, and data collection tools that eliminate waste in healthcare,” said John Criswell, CEO of Pulse8. “TripleTree’s insight and deep understanding of our business was a powerful resource in finding a strategic partner that could help accelerate our growth and capitalize on Pulse8’s significant market opportunity.” 
 
TripleTree acted as the exclusive financial advisor to Pulse8 for this transaction.
 
About TripleTree
TripleTree is an independent merchant bank focused on mergers and acquisitions, growth capital, recapitalizations, strategic advisory and principal investing. Since 1997, the firm has advised and invested in some of the most innovative, high-growth businesses in healthcare. For more, visit www.triple-tree.com.

About Pulse8
Pulse8 is the only Healthcare Analytics and Technology Company delivering complete visibility into the efficacy of your Risk Adjustment, Quality, and Pharmacy Benefit Management programs. We enable health plans and providers to eliminate waste and achieve the greatest financial impact in the Medicare Advantage, Medicaid, and ACA Commercial markets as well as with Value-Based Payment models for Medicare. Our advanced analytic methodologies and flexible business intelligence tools offer real-time visibility into member behavior and provider performance. Pulse8’s Illumin8 Active Intelligence™ platform offers a suite of uniquely pragmatic solutions that are powered by our patent-pending Dynamic Intervention Planning to deliver the most cost-effective and appropriate interventions for closing gaps in documentation, coding, and quality. For more company information or to schedule a demo, please contact Scott Filiault at (732) 570-9095 or scott.filiault@pulse8.com.